Literature DB >> 9348242

Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells.

J Arts1, G G Kuiper, J M Janssen, J A Gustafsson, C W Löwik, H A Pols, J P van Leeuwen.   

Abstract

Estrogens have been shown to be essential for maintaining a sufficiently high bone mineral density and ER alpha expression has been demonstrated in bone cells. Recently, a novel estrogen receptor, estrogen receptor beta (ERbeta) has been identified. Here we demonstrate that also ERbeta is expressed in human osteoblasts, and that ER alpha and ERbeta are differentially expressed during human osteoblast differentiation. ERbeta mRNA expression increased gradually during osteoblast culture, resulting in an average increase of 9.9+/-5.3 fold (mean+/-S.D., n=3) at day 21 (mineralization phase) as compared to day 6 (proliferation phase). In contrast, ER alpha mRNA expression levels increased only slightly until day 10 (2.3+/-1.7 fold) and then remained constant. The observed differential regulation of ER alpha and beta is suggestive for an additional functional role of ERbeta to ER alpha in bone metabolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9348242     DOI: 10.1210/endo.138.11.5652

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  37 in total

Review 1.  Skeletal effects of estrogens.

Authors:  G Fiorelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 2.  Estrogen receptor and the SERM concept.

Authors:  G G Kuiper; G J van den Bemd; J P van Leeuwen
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 3.  Selective drug delivery to bone using acidic oligopeptides.

Authors:  Junko Ishizaki; Yoshihiro Waki; Tatsuo Takahashi-Nishioka; Koichi Yokogawa; Ken-Ichi Miyamoto
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

4.  Estrogen directly down-regulates the bone-resorbing activity of mature osteoclasts through nuclear estrogen receptor alpha.

Authors:  H Mano; Y Hakeda; M Kumegawa
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

5.  Estrogen-mediated effects on cognition and synaptic plasticity: what do estrogen receptor knockout models tell us?

Authors:  Hyun Jin Kim; Gemma Casadesus
Journal:  Biochim Biophys Acta       Date:  2010-05-12

6.  Association of estrogen receptor β and estrogen-related receptor α gene polymorphisms with bone mineral density in postmenopausal women.

Authors:  Amira Shoukry; Sally M Shalaby; Rasha L Etewa; Hanan S Ahmed; Hossam M Abdelrahman
Journal:  Mol Cell Biochem       Date:  2015-04-24       Impact factor: 3.396

Review 7.  Men, bone and estrogen: unresolved issues.

Authors:  E S Orwoll
Journal:  Osteoporos Int       Date:  2003-03-04       Impact factor: 4.507

Review 8.  Isoflavones and skeletal health: are these molecules ready for clinical application?

Authors:  S Migliaccio; J J B Anderson
Journal:  Osteoporos Int       Date:  2003-04-29       Impact factor: 4.507

9.  Bisphenol AF is a full agonist for the estrogen receptor ERalpha but a highly specific antagonist for ERbeta.

Authors:  Ayami Matsushima; Xiaohui Liu; Hiroyuki Okada; Miki Shimohigashi; Yasuyuki Shimohigashi
Journal:  Environ Health Perspect       Date:  2010-04-28       Impact factor: 9.031

10.  Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis.

Authors:  Yvonne H Sniekers; Harrie Weinans; Gerjo J V M van Osch; Johannes P T M van Leeuwen
Journal:  Arthritis Res Ther       Date:  2010-10-05       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.